CIAM
SGP

Caitong International Asset Management’s SpyGlass Pharma SGP Stock Holding History

Caitong International Asset Management’s Portfolio SGP Stock Details SGP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223 Buy
+10
New +$217 ﹤0.01% 1979

Other funds holding SGP

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

Caitong International Asset Management's SGP Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in SpyGlass Pharma (SGP) in Q2 2026: 10 shares worth $223. The stake represents ﹤0.01% of the portfolio and ranks #1979 among its holdings.

9 funds tracked by Wall St. Rank hold SGP as of Q2 2026.

  • Caitong International Asset Management held 10 shares of SpyGlass Pharma worth $223 as of Q2 2026.
  • SpyGlass Pharma was a new Caitong International Asset Management position in Q2 2026.
  • SpyGlass Pharma made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1979 holding.
  • 9 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.